Evidence map›Paper›PMID 33857895›Full record

ArticleWater research2021

Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein.

G La Rosa, P Mancini, G Bonanno Ferraro, C Veneri, M Iaconelli, L Lucentini, L Bonadonna, S Brusaferro, D Brandtner, A Fasanella and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Water research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

G La RosaDepartment of Environment and Health, Italian National Institute of Health, Rome, Italy. Electronic address: giuseppina.larosa@iss.it.
P ManciniDepartment of Environment and Health, Italian National Institute of Health, Rome, Italy.
G Bonanno FerraroDepartment of Environment and Health, Italian National Institute of Health, Rome, Italy.
C VeneriDepartment of Environment and Health, Italian National Institute of Health, Rome, Italy.
M IaconelliDepartment of Environment and Health, Italian National Institute of Health, Rome, Italy.
L LucentiniDepartment of Environment and Health, Italian National Institute of Health, Rome, Italy.
L BonadonnaDepartment of Environment and Health, Italian National Institute of Health, Rome, Italy.
S BrusaferroOffice of the President, Istituto Superiore di Sanità, Rome, Italy.
D BrandtnerIndependent Researcher, Rome, Italy.
A FasanellaExperimental Zooprophylactic Institute of the Apulia and Basilicata Regions, Foggia, Italy.
L PaceExperimental Zooprophylactic Institute of the Apulia and Basilicata Regions, Foggia, Italy.
A ParisiExperimental Zooprophylactic Institute of the Apulia and Basilicata Regions, Foggia, Italy.
D GalanteExperimental Zooprophylactic Institute of the Apulia and Basilicata Regions, Foggia, Italy.
E SuffrediniDepartment of Food Safety, Nutrition and Veterinary Public Health, Italian National Institute of Health, Rome, Italy.
Istituto Zooprofilattico Sperimentale della Puglia e della Basilicata · ITIstituto Superiore di Sanità · ITNational Institute of Health · AM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New SARS-CoV-2 mutations are constantly emerging, raising concerns of increased transmissibility, virulence or escape from host immune response. We describe a nested RT-PCR assay (~1500 bps) to detect multiple nucleotide changes resulting in key spike protein mutations distinctive of the major known circulating SARS-CoV-2 variants, including the three Variants of Concern (VOCs) 20I/501Y.V1 (United Kingdom), 20H/501Y.V2 (South Africa), and 20 J/501Y.V3 (Brazil), as well as the 20E.EU1 variant (Spain), the CAL.20C recently identified in California, and the mink-associated variant (GR, lineage B.1.1.298). Prior to application to field samples, the discriminatory potential of this PCR assay was explored using GISAID and Nextclade. To extend variant detection to challenging matrices such as sewage, where the amplification of long fragments is problematic, two short nested RT-PCR assays (~300 bps) were also designed, targeting portions of the region spanned by the long nested assay. The three newly-designed assays were then tested on field samples, including 31 clinical samples (7 fully-sequenced swab samples, and 24 uncharacterized ones) and 34 urban wastewater samples, some of which collected in areas where circulation of VOCs had been reported. The long assay successfully amplified 29 of the 31 swabs (93%), allowing the correct identification of variants 20I/501Y.V1 and 20E.EU1 present in the panel of previously characterized samples. The Spanish variant was detected in 14/24 of the uncharacterized samples as well. The sequences obtained using the short assays were consistent with those obtained with the long assay. Mutations characteristic of VOCs (UK and Brazilian variant) and of other variant (Spanish) were detected in sewage samples. To our knowledge, this is the first evidence of the presence of sequences harboring key mutations of 20I/501Y.V1 and 20 J/501Y.V3 in urban wastewaters, highlighting the potential contribution of wastewater surveillance to explore SARS-CoV-2 diversity. The developed nested RT-PCR assays can be used as an initial rapid screening test to select clinical samples containing mutations of interest. This can speed up diagnosis and optimize resources since it allows full genome sequencing to be done only on clinically relevant specimens. The assays can be also employed for a rapid and cost-effective detection of VOCs or other variants in sewage for the purposes of wastewater-based epidemiology. The approach proposed here can be used to better understand SARS-CoV-2 variant diversity, geographic distribution and impact worldwide.

Indexed as

COVID-19SARS-CoV-2BrazilHumansMutationReverse Transcriptase Polymerase Chain ReactionSouth AfricaSpainSpike Glycoprotein, CoronavirusUnited KingdomSpike Glycoprotein, CoronavirusMutationPCRSARS-CoV-2SequencingVariantVOC

Identifiers

PMID33857895
PMCPMC8018700
OpenAlexW3143539758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.